Table 1 Study participants baseline characteristics
Patient ID | Gender | Age | Ethnicity | Race | Years since HIV diagnosis | Years on ART | Years of continual viral suppression | CD4 nadir recorded at first diagnosis | Current ART regimen | CD4 Count on day of collection | Viral load Count on day of collection |
|---|---|---|---|---|---|---|---|---|---|---|---|
BEAT-045 | Male | 45 | Not Hispanic | AA | 24 | 18 | 11 | 77 | Triumeq | 573 | <20 |
BEAT2-010 | Male | 60 | Not Hispanic | White | 24 | 23 | 2 | >200 | Biktarvy | 1219 | <20 |
BEAT2-015 | Male | 62 | Not Hispanic | AA | 27 | 20 | 12 | >200 | Triumeq | 396 | <20 |
Yale-017 | Male | 43 | Not Hispanic | AA | 19 | 19 | 12 | 349 | Symtuza | 653 | 51 |
Yale-013 | Male | 57 | Not Hispanic | AA | 20 | 18 | 17 | 425 | Biktarvy | 694 | <20 |
LTA-019 | Male | 72 | Not Hispanic | AA | 35 | 20 | 18 | 126 | Biktarvy | 921 | <20 |
LTA-013 | Male | 56 | Not Hispanic | AA | 34 | 13 | 13 | 372 | Biktarvy | 411 | <20 |
